Champignon Featured in Broadcast on Mental Health Options, Medical Mushrooms
NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) — via NetworkNewsAudio – Champignon Brands Inc. (OTC:SHRMF) (CSE:SHRM) announces the availability of a […]
Manhattan Associates Provides Corporate Update in Response to COVID-19
ATLANTA, April 03, 2020 (GLOBE NEWSWIRE) — Manhattan Associates Inc. (NASDAQ: MANH) is providing the following corporate update in response […]
La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at University Hospital Frankfurt in Germany
SAN DIEGO, April 03, 2020 (GLOBE NEWSWIRE) — La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development […]
Kaleido Biosciences Appoints Anne Prener, M.D., Ph.D., to its Board of Directors
LEXINGTON, Mass., April 03, 2020 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven […]
Trxade Featured in Broadcast on Much-Needed Solutions to Healthcare Dilemma
NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) — via NetworkNewsAudio – Trxade Group Inc. (NASDAQ: MEDS) announces the availability of a […]
iClick Featured in Broadcast on Acceleration of Online Marketing in China
NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) — via NetworkNewsAudio – iClick Interactive Asia Group (NASDAQ:ICLK)Bay Street News
Voyager Therapeutics Provides Update on the RESTORE-1 Parkinson’s Disease Trial
CAMBRIDGE, Mass., April 03, 2020 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on […]
TSX News -
UNISYNC UPDATE ON COVID-19 AFFECT ON OPERATIONS
TORONTO, April 03, 2020 (GLOBE NEWSWIRE) — Unisync is a broad-based vertically integrated North American enterprise with exceptional capabilities in […]
Novan Receives Verbal Guidance from FDA for SB206 and Announces Sato Program Advancement
Per verbal guidance, FDA to consider one additional pivotal trialFDA-generated minutes expected on or before May 1, 2020Sato Pharmaceutical to […]
I-Mab Announces IND Clearance from FDA for TJM2 to Treat Cytokine Release Syndrome (CRS) Associated with Severe Coronavirus Disease 19 (COVID-19)
SHANGHAI, China and ROCKVILLE, MD., April 03, 2020 (GLOBE NEWSWIRE) — I-Mab (Nasdaq: IMAB) ( the “Company”), a clinical stage […]
